- Home
- TOYO vs BIOA Comparison
TOYO vs BIOA Comparison
Compare TOYO & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOYO
- BIOA
- Stock Information
- Founded
- TOYO 2022
- BIOA 2015
- Country
- TOYO Japan
- BIOA United States
- Employees
- TOYO N/A
- BIOA N/A
- Industry
- TOYO
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- TOYO
- BIOA Health Care
- Exchange
- TOYO NYSE
- BIOA Nasdaq
- Market Cap
- TOYO 153.8M
- BIOA 153.4M
- IPO Year
- TOYO N/A
- BIOA 2024
- Fundamental
- Price
- TOYO $3.69
- BIOA $4.28
- Analyst Decision
- TOYO
- BIOA Hold
- Analyst Count
- TOYO 0
- BIOA 4
- Target Price
- TOYO N/A
- BIOA $5.67
- AVG Volume (30 Days)
- TOYO 12.5K
- BIOA 338.3K
- Earning Date
- TOYO 08-21-2025
- BIOA 08-15-2025
- Dividend Yield
- TOYO N/A
- BIOA N/A
- EPS Growth
- TOYO 350.49
- BIOA N/A
- EPS
- TOYO 1.09
- BIOA N/A
- Revenue
- TOYO $176,957,128.00
- BIOA $1,451,000.00
- Revenue This Year
- TOYO N/A
- BIOA N/A
- Revenue Next Year
- TOYO N/A
- BIOA N/A
- P/E Ratio
- TOYO $3.40
- BIOA N/A
- Revenue Growth
- TOYO 183.69
- BIOA N/A
- 52 Week Low
- TOYO $1.36
- BIOA $2.88
- 52 Week High
- TOYO $7.22
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- TOYO N/A
- BIOA N/A
- Support Level
- TOYO N/A
- BIOA N/A
- Resistance Level
- TOYO N/A
- BIOA N/A
- Average True Range (ATR)
- TOYO 0.00
- BIOA 0.00
- MACD
- TOYO 0.00
- BIOA 0.00
- Stochastic Oscillator
- TOYO 0.00
- BIOA 0.00
About TOYO TOYO CO LTD
Toyo Co Ltd along with its subsidiaries, is engaged in research and development, production, and sales of solar cells. Geographically, the company generates revenue from Asia and the USA, out of which the majority of revenue is generated from Asia.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.